Oxford Developed Covid Vaccine, Then Scholars Clashed Over Money
An early deal with Merck was scotched for fear poor countries would be left out; now the university could make over $100 million with AstraZeneca if the technology succeeds.
為什麼AZ最便宜，因為她放棄專利權，我們應該向她致敬 ❤️
溫布頓網球賽的中央球場，是所有網球迷的經典朝聖地。不過今天讓全場陷入沸騰、起立致敬鼓掌的不是網球冠軍選手，而是這位紅衣服的女士，她就是AZ疫苗的發明者之一，牛津大學疫苗學教授 Sarah Gilbert！
在全球疫情肆虐下，AZ疫苗的快速問世挽救了許多生命，雖然AZ不一定是最先進的疫苗，但佛心般的價格，帶有濃厚公益性質的牛津AZ疫苗，才是全世界普羅大眾的真正救星。她主動放棄專利權，一劑只約2-3美金 🌺
她還是三胞胎的媽媽，學術研究和媽媽角色兼顧，真是不簡單 🍎
溫布頓網球賽的中央球場，是所有網球迷的經典朝聖地。不過今天讓全場陷入沸騰、起立致敬鼓掌的不是網球冠軍選手，而是這位紅衣服的女士，她就是AZ疫苗的發明者之一，牛津大學疫苗學教授 Sarah Gilbert！
在全球疫情肆虐下，AZ疫苗的快速問世挽救了許多生命，雖然AZ不一定是最先進的疫苗，但佛心般的價格，帶有濃厚公益性質的牛津AZ疫苗，才是全世界普羅大眾的真正救星。她主動放棄專利權，一劑只約2-3美金 🌺
她還是三胞胎的媽媽，學術研究和媽媽角色兼顧，真是不簡單 🍎
Past 31 days
Total Visit: 0
Asdfgh mark this message contains misinformation
｜originally written by Asdfgh
Sarah Gilbert 沒有放棄「專利權」，目前是牛津大學擁有疫苗的獨家權利。
他們跟 AstraZeneca 的協議是：在新冠肺炎大流行期間，要以成本價出售 AZ 疫苗至少30億劑，之後繼續出售的疫苗，牛津大學則按照協議收取權利金，如果病毒流感化，這個收益可以幫助大學進行更多研究。
這是一則修改自正確訊息的謠言，後面「具有公益性質」是對的，但是「為什麼AZ最便宜，因為她放棄專利權」是錯的。
他們跟 AstraZeneca 的協議是：在新冠肺炎大流行期間，要以成本價出售 AZ 疫苗至少30億劑，之後繼續出售的疫苗，牛津大學則按照協議收取權利金，如果病毒流感化，這個收益可以幫助大學進行更多研究。
這是一則修改自正確訊息的謠言，後面「具有公益性質」是對的，但是「為什麼AZ最便宜，因為她放棄專利權」是錯的。
References
https://www.wsj.com/articles/oxford-developed-covid-vaccine-then-scholars-clashed-over-money-11603300412?fbclid=IwAR1DXmkBHLA7ybIHoAc_Wf8_ERHq_IPHACaJTj23gHYFBZhIi180r-jGGVAhttps://innovation.ox.ac.uk/technologies-available/technology-licensing/expedited-access-covid-19-related-ip/
https://healthpolicy-watch.news/ip-not-the-main-barrier-to-equitable-vaccine-rollout-say-two-leading-pharma-execs-at-who-press-conference/
https://www.ft.com/content/c474f9e1-8807-4e57-9c79-6f4af145b686
https://www.reuters.com/article/us-health-coronavirus-who-ip-idUSKBN2B0269
https://www.wsj.com/articles/oxford-developed-covid-vaccine-then-scholars-clashed-over-money-11603300412?fbclid=IwAR1DXmkBHLA7ybIHoAc_Wf8_ERHq_IPHACaJTj23gHYFBZhIi180r-jGGVA
Expedited access for COVID-19 related IP - Oxford University Innovation
The COVID-19 pandemic demands an urgent and unprecedented response. University research and expertise is critical ...
Cannot get data from URL
Subscribe to read | Financial Times
News, analysis and comment from the Financial Times, the worldʼs leading global business publication
Waiving patents alone won't solve COVID-19 vaccine access: developers
Waiving intellectual property rights will not be enough to resolve COVID-19 vaccine access issues, the developers of the Oxford/Astrazeneca and the Pfizer/BioNTech vaccines said on Monday, ahead of a
章王科 mark this message contains misinformation
｜originally written by 章王科
原始的新聞只講到他在溫布頓被感謝，沒講到他放棄專利(詳連結1)
實際上他不認為放棄專利有注疫情,更多廠商研發疫苗才是(詳連結2)
另外AZ便宜的原因是這個公司聲明在疫情期間不以獲利為目標(詳連結3)
實際上他不認為放棄專利有注疫情,更多廠商研發疫苗才是(詳連結2)
另外AZ便宜的原因是這個公司聲明在疫情期間不以獲利為目標(詳連結3)
References
連結1 新聞稿https://www.independent.co.uk/news/uk/home-news/wimbledon-covid-vaccine-sarah-gilbert-b1874316.html
連結2 他不認為放棄專利有注疫情,更多廠商研發疫苗才是
https://healthpolicy-watch.news/ip-not-the-main-barrier-to-equitable-vaccine-rollout-say-two-leading-pharma-execs-at-who-press-conference/
連結3 AZ公司聲明在疫情期間不以獲利為目標
https://www.ft.com/content/c474f9e1-8807-4e57-9c79-6f4af145b686
Wimbledon crowd gives standing ovation to Oxford Covid vaccine developer
Tennis fans show support for vaccine scientists and keyworkers on first day at Centre Court
Cannot get data from URL
Subscribe to read | Financial Times
News, analysis and comment from the Financial Times, the worldʼs leading global business publication
H PAs mark this message contains misinformation
｜originally written by H PAs
關於專利權的訊息查不到相關內容，三月時還有Gilbert認為放棄專利對疫苗普及不會有幫助的新聞，可見後面將放棄專利ㄧ疫苗價格ㄧ作連結的方有可質疑之處
References
https://www.reuters.com/article/us-health-coronavirus-who-ip-idUSKBN2B0269Waiving patents alone won't solve COVID-19 vaccine access: developers
Waiving intellectual property rights will not be enough to resolve COVID-19 vaccine access issues, the developers of the Oxford/Astrazeneca and the Pfizer/BioNTech vaccines said on Monday, ahead of a
Chicco Huang mark this message contains true information
｜originally written by Chicco Huang
牛津大學網站的確說明釋出有條件的COVID疫苗智財權。
References
https://innovation.ox.ac.uk/technologies-available/technology-licensing/expedited-access-covid-19-related-ip/Expedited access for COVID-19 related IP - Oxford University Innovation
The COVID-19 pandemic demands an urgent and unprecedented response. University research and expertise is critical ...
LiangLiang Lo mark this message invalid request
｜originally written by LiangLiang Lo
There are 1 reply deleted by its author.
The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.
查謠言詐騙